About
PreciseDx develops an AI-powered diagnostic platform called PreciseBreast® that analyzes breast cancer tissue samples to provide rapid and objective risk stratification of disease recurrence, improving upon traditional tumor grading and gene expression testing.
Explore PreciseDx's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.